Revenue: solid performance (up 7.4%, with 4.5% organic growth) Operating profit before non-recurring items (EBIT-A) (1): €45.0 million (up 11.7%) Wider EBIT-A margin: 6.8% (up 0.2 pt) Stable dividend ...
Futures Contracts: Diversifying Financial Instruments And Building A Competitive, Transparent Market
(MENAFN- Daily News Egypt) The decision by the Financial Regulatory Authority (FRA) to grant the Egyptian Exchange (EGX) a licence to establish and operate a futures exchange marks a pivotal moment in ...
Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) announced that it has entered into agreements, together with certain of its affiliates (collectively, “Fairfax”), to sell an aggregate of 67,618 ...
Vermilion Energy Inc. ("Vermilion" or the "Company") (TSX: VET) (NYSE: VET) is pleased to report operating and condensed financial results for the year ended December 31, 2025.
Net debt pre-IFRS 16 and IAS 17 after deduction of Ages & Vie receivables i.e €2,987m /consolidated EBITDA restated for the impact of IFRS 16 and IAS 17 and adjusted for certain non-cash items and the ...
Major Drilling Group International Inc. (“Major Drilling” or the “Company”) (TSX: MDI), the largest provider of drilling services to the mining ...
FULL-YEAR RESULTS PAREF strengthens its fundamentals and initiates strategic refocusing REIT activity: a portfolio in transition in a challenging market €174m of owned asset, decreasing by ...
(All financial figures are unaudited and in Canadian dollars unless otherwise noted. * identifies non-GAAP financial measures. Please refer to Non-GAAP Reconciliations Appendices.) ...
Preliminary Statement of Results for the year ended 31 December 2025 Irish Continental Group (ICG), the leading Irish-based maritime transport group, reports its financial performance for the year ...
All of the amounts disclosed in this press release are in U.S. dollars unless otherwise notedTEL AVIV, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) ...
In other recent news, Lumentum reported impressive financial results for the second quarter of fiscal year 2026, with earnings per share (EPS) of $1.67, surpassing the forecast of $1.39. The company’s ...
Pharma Equity Group A/S ("the Company") has received a decision from the Danish Business Authority dated 20 November 2025 regarding the Authority's control of the Company's annual reports for 2023 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results